Aspire Private Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8
| Closed | -$2.77K | – | 696 |
|
|
2024
Q1 | $2.77K | Hold |
8
| – | – | ﹤0.01% | 553 |
|
|
2023
Q4 | $2.58K | Hold |
8
| – | – | ﹤0.01% | 540 |
|
|
2023
Q3 | $2.87K | Hold |
8
| – | – | ﹤0.01% | 534 |
|
|
2023
Q2 | $3.03K | Hold |
8
| – | – | ﹤0.01% | 504 |
|
|
2023
Q1 | $3.83K | Sell |
8
-1
| -11% | -$479 | ﹤0.01% | 474 |
|
|
2022
Q4 | $3.78K | Hold |
9
| – | – | ﹤0.01% | 463 |
|
|
2022
Q3 | $4K | Hold |
9
| – | – | ﹤0.01% | 432 |
|
|
2022
Q2 | $4K | Hold |
9
| – | – | ﹤0.01% | 409 |
|
|
2022
Q1 | $5K | Hold |
9
| – | – | ﹤0.01% | 392 |
|
|
2021
Q4 | $7K | Sell |
9
-1
| -10% | -$778 | ﹤0.01% | 366 |
|
|
2021
Q3 | $7K | Hold |
10
| – | – | ﹤0.01% | 335 |
|
|
2021
Q2 | $6K | Sell |
10
-22
| -69% | -$13.2K | ﹤0.01% | 361 |
|
|
2021
Q1 | $18K | Buy |
32
+30
| +1,500% | +$16.9K | 0.01% | 279 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 405 |
|
|
2020
Q3 | $1K | Sell |
2
-31
| -94% | -$15.5K | ﹤0.01% | 408 |
|
|
2020
Q2 | $15K | Buy |
+33
| New | +$15K | 0.01% | 198 |
|